SOUTH SAN FRANCISCO—David Shook, the Chief Medical (TASE:) Officer and Head of Research & Development at Nkarta, Inc. (NASDAQ:NKTX), recently sold shares of the company’s common stock valued at approximately $19,003. According to a recent SEC filing, the sale involved 8,638 shares at a price of $2.20 per share.
Following this transaction, Shook holds 190,955 shares of Nkarta. The shares sold were required to satisfy tax withholding obligations related to the vesting and settlement of Restricted Stock Units, as noted in the filing. This transaction did not represent a discretionary decision by Shook. For deeper insights into NKTX’s valuation and 10+ additional ProTips, visit InvestingPro, where you’ll find comprehensive analysis in our Pro Research Report.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
